Cancer mortality in long-term survivors of retinoblastoma

European Journal of Cancer

Volumn 45, Issue 18, 2009, Pages 3245-3253

  Marees, T ^a   van Leeuwen, F E ^a,b   de Boer, M R ^c   Imhof, S M ^a,d   Ringens, P J ^a   Moll, A C ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

^c VU UNIVERSITY AMSTERDAM   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Long term survivors; Mortality; Retinoblastoma; Second malignancy

Indexed keywords

ARTICLE; CANCER MORTALITY; CANCER RISK; CANCER SURVIVOR; CAUSE OF DEATH; FEMALE; FOLLOW UP; HEREDITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; PRIORITY JOURNAL; RETINOBLASTOMA; SECOND CANCER;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CAUSE OF DEATH; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DEATH CERTIFICATES; FEMALE; GENES, RETINOBLASTOMA; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFANT; MALE; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; NETHERLANDS; POPULATION SURVEILLANCE; REGISTRIES; REGRESSION ANALYSIS; RETINAL NEOPLASMS; RETINOBLASTOMA; RISK FACTORS; SURVIVORS; YOUNG ADULT;

EID: 70450172523     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2009.05.011     Document Type: Article

References (29)

1. Leiderman Y.I., Kiss S., and Mukai S. Molecular genetics of RB1 - the retinoblastoma gene. Semin Ophthalmol 22 (2007) 247-254
2. Abramson D.H. Retinoblastoma in the 20th century: past success and future challenges the Weisenfeld lecture. Invest Ophthalmol Vis Sci 46 (2005) 2683-2691
3. Abramson D.H., Ronner H.J., and Ellsworth R.M. Second tumors in nonirradiated bilateral retinoblastoma. Am J Ophthalmol 87 (1979) 624-627
4. DerKinderen D.J., Koten J.W., Nagelkerke N.J., et al. Non-ocular cancer in patients with hereditary retinoblastoma and their relatives. Int J Cancer 41 (1988) 499-504
5. Desjardins L., Haye C., and Schlienger P. Et al. Second non-ocular tumours in survivors of bilateral retinoblastoma. A 30-year follow-up. Ophthalmic Paediatr Genet 12 (1991) 145-148
6. Draper G.J., Sanders B.M., and Kingston J.E. Second primary neoplasms in patients with retinoblastoma. Br J Cancer 53 (1986) 661-671
7. Fletcher O., Easton D., Anderson K., et al. Lifetime risks of common cancers among retinoblastoma survivors. J Natl Cancer Inst 96 (2004) 357-363
8. Kleinerman R.A., Tucker M.A., Abramson D.H., et al. Risk of soft tissue sarcomas by individual subtype in survivors of hereditary retinoblastoma. J Natl Cancer Inst 99 (2007) 24-31
9. Kleinerman R.A., Tucker M.A., Tarone R.E., et al. Risk of new cancers after radiotherapy in long-term survivors of retinoblastoma: an extended follow-up. J Clin Oncol 23 (2005) 2272-2279
10. Moll A.C., Imhof S.M., Bouter L.M., et al. Second primary tumors in patients with hereditary retinoblastoma: a register-based follow-up study, 1945-1994. Int J Cancer 67 (1996) 515-519
11. Roarty J.D., McLean I.W., and Zimmerman L.E. Incidence of second neoplasms in patients with bilateral retinoblastoma. Ophthalmology 95 (1988) 1583-1587
12. Wong F.L., Boice Jr. J.D., Abramson D.H., et al. Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk. JAMA 278 (1997) 1262-1267
13. Marees T., Moll A.C., Imhof S.M., et al. Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up. J Natl Cancer Inst 100 (2008) 1771-1779
14. Acquaviva A., Ciccolallo L., Rondelli R., et al. Mortality from second tumour among long-term survivors of retinoblastoma: a retrospective analysis of the Italian retinoblastoma registry. Oncogene 25 (2006) 5350-5357
15. Yu C.L., Tucker M.A., Abramson D.H., et al. Cause-specific mortality in long-term survivors of retinoblastoma. J Natl Cancer Inst 101 (2009) 581-591
16. World Health Organisation. International Classification of Diseases for Oncology. 2nd ed. (1990), WHO, Geneva, Switzerland
17. Wolleswinkel-van Den Bosch J.H., Van Poppel F.W., and Mackenbach J.P. Reclassifying causes of death to study the epidemiological transition in the Netherlands, 1875-1992. Eur J Popul 12 (1996) 327-361
18. In: Pearson E.S., and Hartley H.O. (Eds). Biometrika tables for statisticians (1976), Biometrika Trust, London, United Kingdom
19. Gooley T.A., Leisenring W., Crowley J., and Storer B.E. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med 18 (1999) 695-706
20. Eng C., Li F.P., Abramson D.H., et al. Mortality from second tumors among long-term survivors of retinoblastoma. J Natl Cancer Inst 85 (1993) 1121-1128
21. Abramson D.H., and Schefler A.C. Update on retinoblastoma. Retina 24 (2004) 828-848
22. Maccarthy A., Birch J.M., Draper G.J., et al. Retinoblastoma: treatment and survival in Great Britain 1963 to 2002. Br J Ophthalmol 93 (2009) 38-39
23. Balmer A., Zografos L., and Munier F. Diagnosis and current management of retinoblastoma. Oncogene 25 (2006) 5341-5349
24. Maccarthy A., Draper G.J., Steliarova-Foucher E., and Kingston J.E. Retinoblastoma incidence and survival in European children (1978-1997). Report from the Automated Childhood Cancer Information System project. Eur J Cancer 42 (2006) 2092-2102
25. Gallie B.L., Zhao J., Vandezande K., White A., and Chan H.S. Global issues and opportunities for optimized retinoblastoma care. Pediatr Blood Cancer 49 (2007) 1083-1090
26. Rodriguez-Galindo C., Wilson M.W., Chantada G., et al. Retinoblastoma: one world, one vision. Pediatrics 122 (2008) e763-e770
27. Chantada G.L., and Leal-Leal C. Retinoblastoma: an international perspective. In: Singh A.D., Damato B.E., Pe'er J., Murphree A.L., and Perry J.D. (Eds). Clinical ophthalmic oncology. 1st ed. (2007), Elsevier Inc. 417-421
28. de Bree R., Moll A.C., Imhof S.M., Buter J., and Leemans C.R. Subsequent tumors in retinoblastoma survivors: the role of the head and neck surgeon. Oral Oncol 44 (2008) 982-985
29. Landier W., Bhatia S., Eshelman D.A., et al. Development of risk-based guidelines for pediatric cancer survivors: the Children's Oncology Group Long-Term Follow-Up Guidelines from the Children's Oncology Group Late Effects Committee and Nursing Discipline. J Clin Oncol 22 (2004) 4979-4990